News

Pharmabiz15h
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection: Shanghai Monday, June 30, 2025, 15:00 Hrs [IST] Mabwell, an innovative ...
Pharmabiz17h
Biovica International receives European patent for its assay, DiviTum TKa to determine prognosis of cancer
Biovica International receives European patent for its assay, DiviTum TKa to determine prognosis of cancer: Uppsala, Sweden Monday, June 30, 2025, 13:30 Hrs [IST] Biovica Internat ...
Pharmabiz17h
US FDA eliminates REMS for autologous chimeric antigen receptor CAR T cell immunotherapies
US FDA eliminates REMS for autologous chimeric antigen receptor CAR T cell immunotherapies: Maryland Monday, June 30, 2025, 13:00 Hrs [IST] The US Food and Drug Administration (FD ...
Pharmabiz16h
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US: Copenhagen, Denmark Monday, June 30, 2025, 14:00 Hrs [IST] BioPorto A/S, an in vitro diagnostics co ...
Pharmabiz14h
Bone Biologics seeks US patent for bone regeneration technology
Bone Biologics seeks US patent for bone regeneration technology: Burlington, Massachusetts Monday, June 30, 2025, 16:00 Hrs [IST] Bone Biologics Corporation (Bone Biologics), a de ...
Pharmabiz13h
Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product
Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product: Oslo, Norway Monday, June 30, 2025, 17:00 Hrs [IST] Navamedic, a Nordic pha ...
Pharmabiz18h
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...
Pharmabiz20h
Sobi’s Gamifant receives US FDA approval for first-ever treatment for adults and children with MAS in Still's disease
Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...
Pharmabiz19h
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints: Brussels, Belgium Monday, June 30, 2025, 11:00 Hrs [IST] UCB, a ...
Pharmabiz19h
Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals
Torrent Pharmaceuticals has announced acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from New York-based global investment firm KKR, with plans to merge the two entities ...
Pharmabiz22h
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drug ...
Pharmabiz21h
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar: Our Bureau, Mumbai Monday, June 30, 2025, 09:00 Hrs [IST] PharmatechnologyIndex.com Pvt Ltd is pl ...